elafibranor, Placebo
GFT505B-319-1
Phase 3 small_molecule active
Quick answer
elafibranor, Placebo for Primary Biliary Cholangitis is a Phase 3 program (small_molecule) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ipsen Pharma
- Indication
- Primary Biliary Cholangitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active